The transition of rapamycin (sirolimus) from a soil-dwelling byproduct of Easter Island to the center of the longevity drug ethical debate represents a paradigm shift in preventive medicine. While this macrolide remains the only pharmacological intervention proven to extend lifespan across nearly all model organisms, its increasing off-label adoption by healthy "biohackers" has ignited a…